Fatty Acid oxidation disorders in a chinese population in taiwan.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  JIMD Reports

• Publication date

  2013-05-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/8904_2013_236PMID 23700290PMCID PMC3755561
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study from 187 patients. Complementary data

  2014cited by this paper
• Carnitine Uptake Defect (Primary Carnitine Deficiency): Risk in Genotype–Phenotype Correlation

  2013cited by this paper
• Newborn screening for citrin deficiency and carnitine uptake defect using second-tier molecular tests

  2013cited by this paper
• Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study of 187 patients

  2013cited by this paper
• Biochemical, molecular, and clinical characteristics of children with short chain acyl-CoA dehydrogenase deficiency detected by newborn screening in California.

  2012cited by this paper
• Genotype–phenotype correlation in primary carnitine deficiency

  2012cited by this paper
• Enhanced interpretation of newborn screening results without analyte cutoff values

  2012cited by this paper
• Efficacy and outcome of expanded newborn screening for metabolic diseases - Report of 10 years from South-West Germany *

  2011cited by this paper
• Computational analysis of a novel mutation in ETFDH gene highlights its long-range effects on the FAD-binding motif

  2011cited by this paper
• Molecular analysis of 51 unrelated pedigrees with late-onset multiple acyl-CoA dehydrogenation deficiency (MADD) in southern China confirmed the most common ETFDH mutation and high carrier frequency of c.250G>A

  2011cited by this paper
• Positive newborn screen in a normal infant of a mother with asymptomatic very long-chain Acyl-CoA dehydrogenase deficiency.

  2011cited by this paper
• A near-miss: very long chain acyl-CoA dehydrogenase deficiency with normal primary markers in the initial well-timed newborn screening specimen.

  2011cited by this paper
• Newborn screening for disorders of fatty-acid oxidation: experience and recommendations from an expert meeting

  2010cited by this paper
• Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening

  2010cited by this paper
• Current issues regarding treatment of mitochondrial fatty acid oxidation disorders

  2010cited by this paper
• Diagnoses of newborns and mothers with carnitine uptake defects through newborn screening.

  2010cited by this paper
• Maternal systemic primary carnitine deficiency uncovered by newborn screening: Clinical, biochemical, and molecular aspects

  2010cited by this paper
• Nationwide survey of extended newborn screening by tandem mass spectrometry in Taiwan

  2010cited by this paper
• High frequency of ETFDH c.250G>A mutation in Taiwanese patients with late‐onset lipid storage myopathy

  2010cited by this paper
• Very long-chain acyl-CoA dehydrogenase deficiency in a patient with normal newborn screening by tandem mass spectrometry.

  2010cited by this paper
• Tandem mass spectrometry screening for very long-chain acyl-CoA dehydrogenase deficiency: the value of second-tier enzyme testing.

  2010cited by this paper
• ETFDH mutations, CoQ10 levels, and respiratory chain activities in patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.

  2009cited by this paper
• Management and outcome in 75 individuals with long-chain fatty acid oxidation defects: results from a workshop

  2009cited by this paper
• Treatment recommendations in long-chain fatty acid oxidation defects: consensus from a workshop

  2009cited by this paper
• Metabolic Myopathies: Update 2009

  2009cited by this paper
• Hypoketotic Hypoglycemia with Myolysis and Hypoparathyroidism: An Unusual Association in Medium Chain Acyl-CoA Desydrogenase Deficiency (MCADD)

  2009cited by this paper
• Carnitine‐palmitoyltransferase 2 deficiency: Novel mutations and relevance of newborn screening

  2008cited by this paper
• Mitochondrial fatty-acid oxidation disorders.

  2008cited by this paper
• Mitochondrial fatty acid oxidation defects—remaining challenges

  2008cited by this paper
• Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China: A four-year report

  2007cited by this paper
• Newborn Screening: Toward a Uniform Screening Panel and System—Executive Summary

  2006cited by this paper
• Tandem mass neonatal screening in Taiwan--report from one center.

  2006cited by this paper
• A systematic review of the role of bisphosphonates in metastatic disease.

  2004cited by this paper
• Clinical-effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: A systematic review

  2004cited by this paper
• L-Carnitine transport in human placental brush-border membranes is mediated by the sodium-dependent organic cation transporter OCTN2.

  2004cited by this paper
• Screening newborns for inborn errors of metabolism by tandem mass spectrometry.

  2003cited by this paper
• Diagnosis of inherited disorders of liver metabolism

  2003cited by this paper
• A founder mutation (R254X) of SLC22A5 (OCTN2) in Chinese primary carnitine deficiency patients

  2002cited by this paper
• Management of fatty acid oxidation disorders: a survey of current treatment strategies.

  2002cited by this paper
• Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program.

  2001cited by this paper
• Carnitine transporter defect diagnosed by newborn screening with electrospray tandem mass spectrometry.

  2001cited by this paper
• Mutation analysis in mitochondrial fatty acid oxidation defects: Exemplified by acyl‐CoA dehydrogenase deficiencies, with special focus on genotype–phenotype relationship

  2001cited by this paper
• Defects in activation and transport of fatty acids

  1999cited by this paper
• Disorders of mitochondrial fatty acyl-CoA β-oxidation

  1999cited by this paper
• Disorders of mitochondrial fatty acyl-CoA beta-oxidation.

  1999cited by this paper
• Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children.

  1999cited by this paper
• Cloning and characterization of human very-long-chain acyl-CoA dehydrogenase cDNA, chromosomal assignment of the gene and identification in four patients of nine different mutations within the VLCAD gene.

  1996cited by this paper
• Tandem mass spectrometry: A new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism

  1990cited by this paper

• Prevalence and Mutation Analysis of Medium-Chain Acyl-CoA Dehydrogenase Deficiency Detected by Newborn Screening in Hefei, China

  2025cites this paper
• A pharmacological profile of triheptanoin for the treatment of long-chain fatty acid oxidation disorders

  2025cites this paper
• Secondary Carnitine Deficiency in Neonates and Infants Requiring Surgery for Intestinal Obstructions—An Underestimated and Undermanaged Problem

  2024influential citation
• Newborn Screening of Primary Carnitine Deficiency: An Overview of Worldwide Practices and Pitfalls to Define an Algorithm before Expansion of Newborn Screening in France

  2023cites this paper
• Newborn Screening for Mitochondrial Carnitine-Acylcarnitine Cycle Disorders in Zhejiang Province, China

  2022cites this paper
• The modern face of newborn screening.

  2022cites this paper
• Estimating the Prevalence of Rare Diseases: Long-Chain Fatty Acid Oxidation Disorders as an Illustrative Example

  2022cites this paper
• Very long‐chain acyl‐CoA dehydrogenase deficiency in a Swedish cohort: Clinical symptoms, newborn screening, enzyme activity, and genetics

  2022cites this paper
• A systematic review of late-onset and very-late-onset multiple acyl-coenzyme a dehydrogenase deficiency: Cohort analysis and patient report from Taiwan.

  2021cites this paper
• Impact of newborn screening on the reported incidence and clinical outcomes associated with medium- and long-chain fatty acid oxidation disorders

  2021cites this paper
• ETF dehydrogenase advances in molecular genetics and impact on treatment

  2021cites this paper
• Screening and follow-up results of fatty acid oxidative metabolism disorders in 608 818 newborns in Jining, Shandong province.

  2021cites this paper
• Screening of multiple acyl-CoA dehydrogenase deficiency in newborns and follow-up of patients.

  2021cites this paper
• Clinical, pathological and genetic features and follow-up of 110 patients with late-onset MADD: A single-center retrospective study.

  2021cites this paper
• Clinical Presentations and Genetic Characteristics of Late-Onset MADD Due to ETFDH Mutations in Five Patients: A Case Series

  2021cites this paper
• Newborn screening for primary carnitine deficiency in Quanzhou, China.

  2020cites this paper
• [Medium-chain acyl-CoA dehydrogenase deficiency: neonatal screening and follow-uP].

  2019cites this paper
• Medium‐chain acyl‐coenzyme A dehydrogenase deficiency: Six cases in the Chinese population

  2019cites this paper
• New Ratios for Performance Improvement for Identifying Acyl-CoA Dehydrogenase Deficiencies in Expanded Newborn Screening: A Retrospective Study

  2019cites this paper
• One Potential Hotspot ACADVL Mutation in Chinese Patients with Very-long-chain Acyl-coenzyme A Dehydrogenase Deficiency.

  2019cites this paper
• Pearls & Oy-sters: A curable myopathy manifesting as exercise intolerance and respiratory failure

  2018cites this paper
• Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency-GeneReviews®-NCBI Bookshelf

  2018cites this paper
• Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle

  2018cites this paper
• A newborn case with carnitine palmitoyltransferase II deficiency initially judged as unaffected by acylcarnitine analysis soon after birth

  2017cites this paper
• [Screening for fatty acid oxidation disorders of newborns in Zhejiang province:prevalence, outcome and follow-up].

  2017cites this paper
• Screening of MCAD deficiency in Japan: 16years' experience of enzymatic and genetic evaluation.

  2016cites this paper
• Inherited metabolic diseases in the Southern Chinese population; Diseases Spectrum and estimated incidence from recurrent mutations

  2016cites this paper
• Recurrent ACADVL molecular findings in individuals with a positive newborn screen for very long chain acyl-coA dehydrogenase (VLCAD) deficiency in the United States.

  2015cites this paper
• Carnitine-acylcarnitine translocase deficiency: experience with four cases in Spain and review of the literature.

  2015cites this paper
• Inherited metabolic diseases in the Southern Chinese population: spectrum of diseases and estimated incidence from recurrent mutations.

  2014influential citation